Sorafenib Accord Unió Europea - islandès - EMA (European Medicines Agency)

sorafenib accord

accord healthcare s.l.u. - sorafenib tosilate - carcinoma, hepatocellular; carcinoma, renal cell - Æxlishemjandi lyf - hepatocellular carcinomasorafenib accord is indicated for the treatment of hepatocellular carcinoma (see section 5. renal cell carcinomasorafenib accord is indicated for the treatment of patients with advanced renal cell carcinoma who have failed prior interferon-alpha or interleukin-2 based therapy or are considered unsuitable for such therapy.

Acetylcystein Mylan Freyðitafla 200 mg Islàndia - islandès - LYFJASTOFNUN (Icelandic Medicines Agency)

acetylcystein mylan freyðitafla 200 mg

mylan ab* - acetylcysteinum inn - freyðitafla - 200 mg

Lyngonia (Alleviate) Filmuhúðuð tafla 425,25-519,75 mg Islàndia - islandès - LYFJASTOFNUN (Icelandic Medicines Agency)

lyngonia (alleviate) filmuhúðuð tafla 425,25-519,75 mg

florealis ehf. - dry bearberry leaf extract (der 2.5 - 4.5:1) - filmuhúðuð tafla - 425,25-519,75 mg

CitraFleet Mixtúruduft, lausn í skammtapoka 10,0 mg/3,5 g/10,97 g Islàndia - islandès - LYFJASTOFNUN (Icelandic Medicines Agency)

citrafleet mixtúruduft, lausn í skammtapoka 10,0 mg/3,5 g/10,97 g

casen recordati s.l. - natrii picosulfas inn; magnesii oxidum; citric acid - mixtúruduft, lausn í skammtapoka - 10,0 mg/3,5 g/10,97 g

Montelukast ratiopharm (Montelukast Teva) Tuggutafla 4 mg Islàndia - islandès - LYFJASTOFNUN (Icelandic Medicines Agency)

montelukast ratiopharm (montelukast teva) tuggutafla 4 mg

teva sweden ab - montelukastum natríum - tuggutafla - 4 mg

Duta Tamsaxiro Hart hylki 0,5/0,4 mg Islàndia - islandès - LYFJASTOFNUN (Icelandic Medicines Agency)

duta tamsaxiro hart hylki 0,5/0,4 mg

medical valley invest ab - dutasteridum inn; tamsulosinum hýdróklóríð - hart hylki - 0,5/0,4 mg

Diamicron Uno Tafla með breyttan losunarhraða 30 mg Islàndia - islandès - LYFJASTOFNUN (Icelandic Medicines Agency)

diamicron uno tafla með breyttan losunarhraða 30 mg

les laboratoires servier* - gliclazidum inn - tafla með breyttan losunarhraða - 30 mg

Duodart Hart hylki 0,5/0,4 mg Islàndia - islandès - LYFJASTOFNUN (Icelandic Medicines Agency)

duodart hart hylki 0,5/0,4 mg

glaxosmithkline pharma a/s - dutasteridum inn; tamsulosinum hýdróklóríð - hart hylki - 0,5/0,4 mg

Dutaprostam Hart hylki 0,5/0,4 mg Islàndia - islandès - LYFJASTOFNUN (Icelandic Medicines Agency)

dutaprostam hart hylki 0,5/0,4 mg

zentiva k.s.* - dutasteridum inn; tamsulosinum hýdróklóríð - hart hylki - 0,5/0,4 mg

Dutasteride/Tamsulosin Teva (Dutasteride/Tamsulosinehydrochloride Teva) Hart hylki 0,5 mg/0,4 mg Islàndia - islandès - LYFJASTOFNUN (Icelandic Medicines Agency)

dutasteride/tamsulosin teva (dutasteride/tamsulosinehydrochloride teva) hart hylki 0,5 mg/0,4 mg

teva b.v.* - dutasteridum inn; tamsulosinum hýdróklóríð - hart hylki - 0,5 mg/0,4 mg